Zymeworks, Inc. (ZYME)
26.97
+0.11
(+0.41%)
USD |
NASDAQ |
Nov 20, 12:23
Zymeworks Free Cash Flow : -111.61M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -111.61M |
| June 30, 2026 | -120.53M |
| March 31, 2026 | -77.62M |
| December 31, 2025 | -35.43M |
| September 30, 2025 | -64.46M |
| June 30, 2025 | -39.19M |
| March 31, 2025 | -76.14M |
| December 31, 2024 | -110.72M |
| September 30, 2024 | -57.14M |
| June 30, 2024 | -94.13M |
| March 31, 2024 | -76.02M |
| December 31, 2023 | -121.27M |
| September 30, 2023 | 182.49M |
| June 30, 2023 | 152.71M |
| March 31, 2023 | 102.14M |
| December 31, 2022 | 125.60M |
| September 30, 2022 | -247.71M |
| June 30, 2022 | -227.73M |
| Date | Value |
|---|---|
| March 31, 2022 | -223.23M |
| December 31, 2021 | -204.61M |
| September 30, 2021 | -201.02M |
| June 30, 2021 | -168.66M |
| March 31, 2021 | -165.36M |
| December 31, 2020 | -162.29M |
| September 30, 2020 | -148.83M |
| June 30, 2020 | -149.05M |
| March 31, 2020 | -113.33M |
| December 31, 2019 | -96.23M |
| September 30, 2019 | -8.609M |
| June 30, 2019 | -2.007M |
| March 31, 2019 | 16.78M |
| December 31, 2018 | 20.37M |
| September 30, 2018 | 11.78M |
| June 30, 2018 | 11.37M |
| March 31, 2018 | -7.086M |
| December 31, 2017 | -2.963M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AbbVie, Inc. | 18.87B |
| Faeth Therapeutics, Inc. | -43.28M |
| ACADIA Pharmaceuticals, Inc. | 81.99M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 2.295M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.34M |
| Cash from Investing (Quarterly) | -386.22M |
| Cash from Financing (Quarterly) | 330.62M |
| Free Cash Flow Per Share (Quarterly) | -0.307 |
| Free Cash Flow to Equity (Quarterly) | -405.05M |
| Free Cash Flow to Firm (Quarterly) | -16.71M |
| Free Cash Flow Yield | -5.77% |